Brandi Glanville Isolated Amid Health Struggles and $7,000 Weekly Medical Bills
Baca dalam 60 detik
- Brandi Glanville mengaku menarik diri dari pergaulan karena teman-temannya meragukan penyakitnya dan mengira itu hanya depresi.
- Bintang reality show ini didiagnosis empat kondisi medis serius, termasuk bakteri resisten antibiotik dan infeksi jamur, dengan biaya pengobatan mencapai ribuan dolar per minggu.
- Teman Glanville membuka penggalangan dana untuk menutupi tagihan medis yang membengkak, menyoroti beban finansial pasien penyakit kronis di Amerika Serikat.

Brandi Glanville, former star of the reality show The Real Housewives of Beverly Hills, revealed she feels isolated from her social circle while battling a series of serious, not yet fully diagnosed illnesses. In an interview with TMZ, the 53-year-old stated that although her friends care, some doubt the reality of her health condition and suspect she is merely experiencing depression.
Glanville admitted that her isolation is partly her own choice. She confessed to being reluctant to answer calls or reply to messages because she has no updates on her illness. "I just want to deal with this myself," she said, adding that the difficulty of explaining her condition to others led her to withdraw.
Glanville's health condition is complex. In an Instagram post, she revealed she has been diagnosed with ESBL Klebsiella and Enterobacter with biofilm—two types of antibiotic-resistant bacteria according to the U.S. Centers for Disease Control and Prevention (CDC)—as well as Coccidioidomycosis (valley fever), Demodex dermatitis, and mononucleosis. Valley fever is a fungal infection that affects the lungs, while Demodex are mites that live in human hair follicles, especially on the face.
Her illness has caused facial disfigurement, and she only has about two hours a day for activities outside the house. This time is usually spent picking up prescriptions at the pharmacy. "I'm so anxious to leave the house, and I just want to be home with my dogs. They love me no matter what I look like," she said.
The financial burden Glanville faces is a particular concern. In an episode of the podcast Brandi and James Maas' Unfiltered, she revealed that despite having insurance, she still has to pay thousands of dollars weekly. "I'm on all these medications, and even with insurance, it's $7,000 a week. And then I have debt collectors calling me all day long," she said. She admitted being ashamed to accept help, but her friend insisted she had no other choice. "If I stop paying, I won't get my medication, and I won't make progress. Right now, I've paid half, and I still owe," she added.
"I don't like asking for help, and I never thought I'd do this. But Gina said, 'You don't have a choice.'" — Brandi Glanville
Glanville's case reflects the challenges faced by many chronic illness patients in the United States, where medical costs can exceed financial capabilities even with health insurance. The private insurance-based healthcare system often leaves gaps in costs that patients must bear themselves, especially for rare or complex diseases requiring long-term care.
For the Indonesian public, this story serves as a mirror reflecting the importance of managing healthcare costs and adequate insurance protection. Although Indonesia has the National Health Insurance (JKN) program, critical and rare diseases still pose an economic burden for many families. Discussions regarding the expansion of coverage and the sustainability of healthcare financing continue, especially amidst the increasing prevalence of non-communicable diseases and antimicrobial resistance.
Glanville currently only socializes with her children, who visit her occasionally. She admits to spending most of her time at home, except for recording her podcast, which sometimes has to be done from her residence. This situation illustrates how serious illnesses not only impact physical health but also the mental well-being and social relationships of those affected.
Moving forward, the question of how healthcare systems—both in the United States and Indonesia—can better protect patients with complex illnesses will become increasingly urgent. Will public fundraising models like Glanville's become the new norm, or is it time for more fundamental policy reforms?



